View in EDS HTML Full Text PDF Full Text

Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.

Saved in:
Bibliographic Details
Title: Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
Authors: Al Rabadi, Luai S.1 (AUTHOR), Cook, Madeline M.2 (AUTHOR), Kaempf, Andy J.3 (AUTHOR), Saraceni, Megan M.4 (AUTHOR), Savin, Michael A.1 (AUTHOR), Mitri, Zahi I.1 (AUTHOR) mitri@ohsu.edu
Source: BMC Cancer. 10/27/2021, Vol. 21 Issue 1, p1-8. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-021-08894-2